Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2398818
Max Phase: Preclinical
Molecular Formula: C39H38BrNO8
Molecular Weight: 728.64
Molecule Type: Small molecule
Associated Items:
ID: ALA2398818
Max Phase: Preclinical
Molecular Formula: C39H38BrNO8
Molecular Weight: 728.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@]12CO[C@@H](c3ccccc3)O[C@H]1CC[C@@]1(C)[C@H]2C[C@H](OC(=O)c2ccc(Br)cc2)[C@@]2(C)Oc3cc(-c4cccnc4)oc(=O)c3[C@H](O)[C@H]12
Standard InChI: InChI=1S/C39H38BrNO8/c1-37-16-15-29-38(2,21-45-36(48-29)23-8-5-4-6-9-23)28(37)19-30(47-34(43)22-11-13-25(40)14-12-22)39(3)33(37)32(42)31-27(49-39)18-26(46-35(31)44)24-10-7-17-41-20-24/h4-14,17-18,20,28-30,32-33,36,42H,15-16,19,21H2,1-3H3/t28-,29+,30+,32+,33-,36-,37+,38+,39-/m1/s1
Standard InChI Key: MOVFSWCSVVAQKY-MKSFZIRSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 728.64 | Molecular Weight (Monoisotopic): 727.1781 | AlogP: 7.43 | #Rotatable Bonds: 4 |
Polar Surface Area: 117.32 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.84 | CX Basic pKa: 4.21 | CX LogP: 6.01 | CX LogD: 6.01 |
Aromatic Rings: 4 | Heavy Atoms: 49 | QED Weighted: 0.21 | Np Likeness Score: 1.36 |
1. Ohtawa M, Yamazaki H, Ohte S, Matsuda D, Ohshiro T, Rudel LL, Ōmura S, Tomoda H, Nagamitsu T.. (2013) Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3., 23 (13): [PMID:23711919] [10.1016/j.bmcl.2013.04.075] |
Source(1):